Minerva Biotechnologies
Biotechnology, 40 Bear Hill Rd, Waltham, Massachusetts, 02451, United States, 11-50 Employees
Phone Number: 78********
Who is MINERVA BIOTECHNOLOGIES
Minerva Biotechnologies is a clinical stage biopharmaceutical company focused on developing immunotherapies for solid tumor cancers and cellular therapies for regenerative medicine. NCT04...
Read More
-
Headquarters: 40 Bear Hill Rd, Waltham, Massachusetts, 02451, United States
-
Date Founded: 1999
-
Employees: 11-50
-
Revenue: $1 Million to $5 Million
-
Active Tech Stack: See technologies
Industry: Biotechnology
SIC Code: 2834
|
NAICS Code: 541715 |
Show More
Does something look wrong? Fix it. | View contact records from MINERVA BIOTECHNOLOGIES
Minerva Biotechnologies Org Chart and Mapping
Email
Phone
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Minerva Biotechnologies
Answer: Minerva Biotechnologies's headquarters are located at 40 Bear Hill Rd, Waltham, Massachusetts, 02451, United States
Answer: Minerva Biotechnologies's phone number is 78********
Answer: Minerva Biotechnologies's official website is https://minervabio.com
Answer: Minerva Biotechnologies's revenue is $1 Million to $5 Million
Answer: Minerva Biotechnologies's SIC: 2834
Answer: Minerva Biotechnologies's NAICS: 541715
Answer: Minerva Biotechnologies has 11-50 employees
Answer: Minerva Biotechnologies is in Biotechnology
Answer: Minerva Biotechnologies contact info: Phone number: 78******** Website: https://minervabio.com
Answer: Minerva Biotechnologies is a clinical stage biopharmaceutical company focused on developing immunotherapies for solid tumor cancers and cellular therapies for regenerative medicine. NCT04020575 is Minervas first-in-human trial of huMNC2-CAR44, a CAR T that targets the MUC1* growth factor receptor, for the treatment of metastatic breast cancers, 95% of which express a MUC1*. We are now expanding the current clinical trial to include our second CAR-T product that greatly increases persistence. The Company is rapidly accelerating its pipeline that includes next-gen CAR-T products, a straight antibody therapeutic and a small molecule therapeutic which are both for the treatment of cancer metastasis. Our track record of scientific breakthroughs is a testament to our visionary team and our collaborative culture. Join us in changing the world.
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month